<DOC>
	<DOCNO>NCT02308865</DOCNO>
	<brief_summary>Single-center , prospective , control , open-label , randomize , two parallel arm compare early Palliative care versus Standard care patient non-small-cell metastatic lung cancer</brief_summary>
	<brief_title>Early Palliative Care Metastatic Lung Cancer Northern France</brief_title>
	<detailed_description>144 patient include ; 72 per arm . - `` Standard '' Control arm : patient support onco-respiratory service . - Intervention arm : patient benefit early palliative care addition standard onco-pneumologic care . The main criterion judgment TOI score measure 12 week . FACTL questionnaires , HADS PHQ-9 fill randomization , 12 week 21 week</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Being diagnose nonsmall cell lung cancer Proven histologically Metastatic proven imaging ( MRI , CT Scanner , PET scan ) Stage IV ( T , N , M1 ) prior secondary chemotherapy treatment . Age &gt; 18 year PS â‰¤2 Patient able understand nature , purpose methodology study sign Informed consent Age &lt; 18 year Patient already support palliative care Patient activate EGFR mutation EML4ALK rearrangement Patient trusteeship / guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Early palliative care</keyword>
	<keyword>Lung cancer</keyword>
	<keyword>Quality life</keyword>
</DOC>